LONDON: Abcam plc announced today the commencement of a registered offering of 8,945,218 American Depositary Shares (ADSs). Each ADS offered represents one ordinary share of Abcam.
The ADSs are being offered in a registered public offering in the United States. All ADSs to be sold in the Offering will be sold by Abcam.
In addition, Abcam expects to grant the underwriters a 30-day option to purchase up to an additional 1,341,782 ADSs on the same terms and conditions.
Abcam has applied to have its ADSs listed on the Nasdaq Global Market under the symbol “ABCM.” Abcam’s ordinary shares are currently admitted to trading on the AIM market of the London Stock Exchange under the symbol “ABC.”
Morgan Stanley and BofA Securities are acting as the lead book-running managers for the Offering. SVB Leerink is acting as a book-running manager, and Lazard and William Blair are acting as co-managers.
The offering will be made only by means of a prospectus. There will be no public offer of the ADSs to the public in the European Economic Area or the United Kingdom.
A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective.
Abcam is a global leader in the supply of life science research tools.